6-(4-环丙基-6-甲氧基嘧啶-5-基)-1-(4-(1-异丙基-4-(三氟甲基)-1H-咪唑-2-基)苄基)-1H-吡唑并[3,4-d]嘧啶
KSQ-4279
产品编号.: | A480971 | CAS号: | 2446480-97-1 |
分子式: | C27H25F3N8O | 分子量: | 534.54 |
纯度: | 98% | MDL NO.: |
中文名称:6-(4-环丙基-6-甲氧基嘧啶-5-基)-1-(4-(1-异丙基-4-(三氟甲基)-1H-咪唑-2-基)苄基)-1H-吡唑并[3,4-d]嘧啶
CAS号:2446480-97-1
中文别名:6-(4-环丙基-6-甲氧基嘧啶-5-基)-1-(4-(1-异丙基-4-(三氟甲基)-1H-咪唑-2-基)苄基)-1H-吡唑并[3,4-d]嘧啶
英文名称:KSQ-4279
英文别名:1H-Pyrazolo[3,4-d]pyrimidine, 6-(4-cyclopropyl-6-methoxy-5-pyrimidinyl)-1-[[4-[1-(1-methylethyl)-4-(trifluoromethyl)-1H-imidazol-2-yl]phenyl]methyl]-;KSQ-4279;HK5F3RGM8P;USP1-IN-1;SCHEMBL22122147;KCBWAFJCKVKYHO-UHFFFAOYSA-N;US11485736, Compound Table 3.15;KSQ-2479;USP1 inhibitor KSQ-4279;SY314463;CS-0374888;A1IB8;MS-29876;1H-Pyrazolo(3,4-d)pyrimidine, 6-(4-cyclopropyl-6-methoxy-5-pyrimidinyl)-1-((4-(1-(1-methylethyl)-4-(trifluoromethyl)-1H-imidazol-2-yl)phenyl)methyl)-;NSC840948;UNII-HK5F3RGM8P;GTPL11964;HY-145471;CHEMBL5095186;6-(4-Cyclopropyl-6-methoxypyrimidin-5-yl)-1-(4-(1-isopropyl-4-(trifluoromethyl)-1H-imidazol-2-yl)benzyl)-1H-pyrazolo[3,4-d]pyrimidine;DA-58922;example 143 [WO2020132269A1];EX-A6085;NSC-840948;6-(4-Cyclopropyl-6-methoxy-5-pyrimidinyl)-1-[4-[1-isopropyl-4-(trifluoromethyl)-2-imidazolyl]benzyl]-1H-pyrazolo[3,4-d]pyrimidine;6-(4-cyclopropyl-6-methoxypyrimidin-5-yl)-1-((4-(1-propan-2-yl-4-(trifluoromethyl)imidazol-2-yl)phenyl)methyl)pyrazolo(3,4-d)pyrimidine;KSQ4279;6-(4-Cyclopropyl-6-methoxypyrimidin-5-yl)-1-[[4-[1-propan-2-yl-4-(trifluoromethyl)imidazol-2-yl]phenyl]methyl]pyrazolo[3,4-d]pyrimidine;Ubiquitin Specific Protease 1 Inhibitor KSQ-4279;Ksq 4279;Z5211048400;example 143 (WO2020132269A1);F96167;2446480-97-1;BDBM580031
EINECS:
分子式:C27H25F3N8O
分子量:534.54
CAS号:2446480-97-1
中文别名:6-(4-环丙基-6-甲氧基嘧啶-5-基)-1-(4-(1-异丙基-4-(三氟甲基)-1H-咪唑-2-基)苄基)-1H-吡唑并[3,4-d]嘧啶
英文名称:KSQ-4279
英文别名:1H-Pyrazolo[3,4-d]pyrimidine, 6-(4-cyclopropyl-6-methoxy-5-pyrimidinyl)-1-[[4-[1-(1-methylethyl)-4-(trifluoromethyl)-1H-imidazol-2-yl]phenyl]methyl]-;KSQ-4279;HK5F3RGM8P;USP1-IN-1;SCHEMBL22122147;KCBWAFJCKVKYHO-UHFFFAOYSA-N;US11485736, Compound Table 3.15;KSQ-2479;USP1 inhibitor KSQ-4279;SY314463;CS-0374888;A1IB8;MS-29876;1H-Pyrazolo(3,4-d)pyrimidine, 6-(4-cyclopropyl-6-methoxy-5-pyrimidinyl)-1-((4-(1-(1-methylethyl)-4-(trifluoromethyl)-1H-imidazol-2-yl)phenyl)methyl)-;NSC840948;UNII-HK5F3RGM8P;GTPL11964;HY-145471;CHEMBL5095186;6-(4-Cyclopropyl-6-methoxypyrimidin-5-yl)-1-(4-(1-isopropyl-4-(trifluoromethyl)-1H-imidazol-2-yl)benzyl)-1H-pyrazolo[3,4-d]pyrimidine;DA-58922;example 143 [WO2020132269A1];EX-A6085;NSC-840948;6-(4-Cyclopropyl-6-methoxy-5-pyrimidinyl)-1-[4-[1-isopropyl-4-(trifluoromethyl)-2-imidazolyl]benzyl]-1H-pyrazolo[3,4-d]pyrimidine;6-(4-cyclopropyl-6-methoxypyrimidin-5-yl)-1-((4-(1-propan-2-yl-4-(trifluoromethyl)imidazol-2-yl)phenyl)methyl)pyrazolo(3,4-d)pyrimidine;KSQ4279;6-(4-Cyclopropyl-6-methoxypyrimidin-5-yl)-1-[[4-[1-propan-2-yl-4-(trifluoromethyl)imidazol-2-yl]phenyl]methyl]pyrazolo[3,4-d]pyrimidine;Ubiquitin Specific Protease 1 Inhibitor KSQ-4279;Ksq 4279;Z5211048400;example 143 (WO2020132269A1);F96167;2446480-97-1;BDBM580031
EINECS:
分子式:C27H25F3N8O
分子量:534.54
搜索质检报告(COA)
搜索MSDS